Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Added: 2 years ago Source:  About the SCCT
Arlington, VA (Oct 28, 2021) — Coronary computed tomographic angiography (CCTA) has been recommended as a frontline testing strategy by the American College of Cardiology (ACC), American Heart Association (AHA), and other groups in the evaluation of patients with stable and acute chest pain who have no known coronary artery disease (CAD). CCTA was given a Class 1 recommendation with level of… View more
Author(s): Haresh Majmundar , Amanda M Donohue , Absalom Hepner , et al Added: 3 years ago
A 63-year-old woman was referred for pre-operative cardiology evaluation prior to elective cholecystectomy. She was experiencing palpitations lasting five to 10 minutes associated with lightheadedness, periodic – sometimes exertional back pain – and had an abnormal electrocardiogram (ECG) (see Figure 1). ECG findings were consistent with: normal sinus rhythm; left atrial enlargement; left… View more

Imaging & Diagnostics

Heart Failure
Author(s): Santo Dellegrottaglie , Pierluigi Costanzo , Stefania Paolillo , et al Added: 3 years ago
In Europe, subjects >65 years of age currently constitute 17% of the entire population, with some variations between countries (see Figure 1).1 More importantly, as a consequence of the ageing population, elderly subjects are expected to account for 30% of the European population by 2050. Currently, cardiovascular disease is the major cause of death in Europe (~20% of all causes) and more than… View more

Imaging & Diagnostics
Author(s): W Kevin Tsai , Kathleen M Holohan , Kim Allan Williams Added: 3 years ago
Coronary artery disease (CAD) represents a tremendous financial and health burden as the leading cause of death in the US.1 Acute coronary syndrome and its subsequent manifestations, including heart failure and need for cardiac transplantation, are associated with significant morbidity and mortality. Hypertension, dyslipidemia, tobacco abuse, diabetes, chronic kidney disease, and family history… View more

Imaging & Diagnostics
Added: 3 years ago Source:  Lantheus Medical Imaging
N. BILLERICA, Mass. (October 29, 2013) – Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced preliminary results from the first of two planned Phase 3 trials to assess the diagnostic efficacy of flurpiridaz F 18, an imaging agent used in Positron Emission Tomography (PET) myocardial perfusion imaging … View more
Author(s): Marianne Arnestad , Panithaya Chareonthaitawee , Beat Andreas Kaufmann , et al Added: 3 years ago
Prevalence of Long-QT Syndrome Gene Variants in Sudden Infant Death Syndrome Arnestad M, et al. Circulation, 2007;115(3):361–7. There are inadequate data regarding the true prevalence of mutations in arrhythmia-susceptibility genes among sudden infant death syndrome (SIDS) cases. Given the importance and potential implications of these observations, the authors performed a study to more… View more

Electrophysiology & Arrhythmia
Author(s): W Kevin Tsai , Kathleen M Holohan , Kim Allan Williams Added: 3 years ago
Coronary artery disease (CAD) represents a tremendous financial and health burden as the leading cause of death in the US.1 Acute coronary syndrome and its subsequent manifestations, including heart failure and need for cardiac transplantation, are associated with significant morbidity and mortality. Hypertension, dyslipidemia, tobacco abuse, diabetes, chronic kidney disease, and family history… View more

Imaging & Diagnostics

Prevention & Chronic Conditions
Author(s): Preeti A Chandra , Ajay Vallakati , Abhinav B Chandra , et al Added: 3 years ago
A 41-year-old male with a six-year history of hyperthyroidism presented with palpitations and dizziness. He had been experiencing the symptoms for the past two months, had lost 37 pounds in weight in the previous 10 weeks, and was heat intolerant. He was taking methimazole 5mg daily. The patient denied chest pain, shortness of breath, and syncope. Physical examination revealed thyroid… View more

Electrophysiology & Arrhythmia
Author(s): Michael I Miyamoto , Kyle A Clarke , Gregory S Thomas , et al Added: 3 years ago
The US Food and Drug Administration (FDA) approved the first selective A2a adenosine receptor agent for myocardial stress perfusion imaging, regadenoson, on April 10, 2008. The chief goal of this second-generation pharmacological stress agent is to selectively and transiently stimulate the A2a receptors to elicit the coronary vasodilation required for pharmacological single-photon-emission… View more

Imaging & Diagnostics